Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12997 | 803 | 19.2 | 48% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1692 | 6172 | FAMILYWISE ERROR RATE//MULTIPLE TESTING//FALSE DISCOVERY RATE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INDIVIDUAL BIOEQUIVALENCE | Author keyword | 67 | 87% | 4% | 33 |
2 | HIGHLY VARIABLE DRUGS | Author keyword | 52 | 87% | 3% | 26 |
3 | BIOEQUIVALENCE | Author keyword | 43 | 16% | 31% | 251 |
4 | POPULATION BIOEQUIVALENCE | Author keyword | 35 | 89% | 2% | 16 |
5 | AVERAGE BIOEQUIVALENCE | Author keyword | 25 | 73% | 2% | 19 |
6 | TWO ONE SIDED TESTS PROCEDURE | Author keyword | 18 | 89% | 1% | 8 |
7 | SCALED BIOEQUIVALENCE LIMITS | Author keyword | 11 | 100% | 1% | 6 |
8 | PHARMACOKINETIC SIMULATIONS | Author keyword | 9 | 83% | 1% | 5 |
9 | SUBJECT BY FORMULATION INTERACTION | Author keyword | 8 | 100% | 1% | 5 |
10 | INTERVAL HYPOTHESIS | Author keyword | 8 | 62% | 1% | 8 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INDIVIDUAL BIOEQUIVALENCE | 62 | 63% | 8% | 62 |
2 | HIGHLY VARIABLE DRUGS | 45 | 62% | 6% | 47 |
3 | SCALED AVERAGE BIOEQUIVALENCE | 35 | 86% | 2% | 18 |
4 | BIOAVAILABILITY BIOEQUIVALENCE | 26 | 87% | 2% | 13 |
5 | LEVELING OFF PROPERTIES | 21 | 85% | 1% | 11 |
6 | COMPARATIVE BIOAVAILABILITY TRIALS | 20 | 56% | 3% | 25 |
7 | SIDED TESTS PROCEDURE | 16 | 48% | 3% | 25 |
8 | TESTING EQUIVALENCE | 11 | 65% | 1% | 11 |
9 | AVERAGE BIOEQUIVALENCE | 11 | 60% | 1% | 12 |
10 | BIOEQUIVALENCE TRIALS | 9 | 52% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Evaluation of Bioequivalence for Highly Variable Drugs with Scaled Average Bioequivalence | 2009 | 18 | 64 | 80% |
Using Partial Area for Evaluation of Bioavailability and Bioequivalence | 2011 | 9 | 15 | 87% |
Individual bioequivalence - New concepts in the statistical assessment of bioequivalence metrics | 1997 | 52 | 11 | 100% |
Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Generic Drug Products by the US Food and Drug Administration | 2012 | 9 | 15 | 87% |
Novel methods to assess bioequivalence | 2011 | 4 | 40 | 80% |
Bioequivalence Requirements in the European Union: Critical Discussion | 2012 | 11 | 14 | 57% |
Variability and Impact on Design of Bioequivalence Studies | 2010 | 10 | 25 | 72% |
Current regulatory approaches of bioequivalence testing | 2012 | 6 | 60 | 72% |
Requirements for generic antiepileptic medicines: a clinical perspective | 2011 | 5 | 37 | 43% |
Measures of exposure versus measures of rate and extent of absorption | 2001 | 27 | 34 | 71% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACOKINET SERV | 6 | 80% | 0.5% | 4 |
2 | PHARMALYT INC | 4 | 75% | 0.4% | 3 |
3 | PHARMACOL CLIN EVALUAT | 3 | 39% | 0.9% | 7 |
4 | REGULATORY AFFAIRS QUAL | 3 | 50% | 0.5% | 4 |
5 | BIOMETR PHARMACOKINET RD | 3 | 60% | 0.4% | 3 |
6 | BIOTECHNOL CLIN DEV | 3 | 60% | 0.4% | 3 |
7 | P DIS BRANCH BACTERIAL MYCOT DIS | 2 | 67% | 0.2% | 2 |
8 | PHARMACOKINET ANALYT STUDIES | 2 | 67% | 0.2% | 2 |
9 | INVENT FARMA GRP | 2 | 50% | 0.4% | 3 |
10 | OFF PHARMACEUT SCI | 2 | 11% | 2.2% | 18 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000173911 | NON INFERIORITY MARGIN//NON INFERIORITY//THREE ARM DESIGN |
2 | 0.0000101595 | PROBABILITY OF CORRECT SELECTION//CORRECT SELECTION//PROBABILITY OF A CORRECT SELECTION |
3 | 0.0000097736 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//DISTRIBUTION CLEARANCE//CURVE MOMENTS |
4 | 0.0000088113 | GENERIC SUBSTITUTION//GENERIC DRUGS//REFERENCE PRICING |
5 | 0.0000082011 | PARALLEL LINE BIOASSAY//SLOPE RATIO BIOASSAY//FIELLER METHOD |
6 | 0.0000070505 | DISSOLUTION TECHNOLOGIES//BIORELEVANT MEDIA//BIOWAIVER |
7 | 0.0000065160 | DIRECTION OF DEPENDENCE//HOMOGENEITY OF COVARIANCE MATRICES//PITMAN MORGAN TEST |
8 | 0.0000062003 | BEHRENS FISHER DISTRIBUTION//PILOT TRIALS//COPC |
9 | 0.0000059240 | ACCURACY PROFILE//ANALYTICAL METHOD TRANSFER//LERMDV |
10 | 0.0000058110 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM//INDIRECT RESPONSE MODELS |